Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-KIR2DL1 Antibody-APC (4W251) is a APC-conjugated Rabbit antibody targeting KIR2DL1. Anti-KIR2DL1 Antibody-APC (4W251) can be used in FCM.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 T | $104 | 7-10 days | 7-10 days | |
| 100 T | $329 | 7-10 days | 7-10 days |
| Description | Anti-KIR2DL1 Antibody-APC (4W251) is a APC-conjugated Rabbit antibody targeting KIR2DL1. Anti-KIR2DL1 Antibody-APC (4W251) can be used in FCM. |
| Synonyms | XXbac-BPG184J6.7, XXbac-BCX195L8.1, p58.1, NKAT-1, NKAT1, NKAT, KIR-K64, KIR221, killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1, CD158A |
| Ig Type | Rabbit IgG |
| Clone | 4W251 |
| Reactivity | Human |
| Specificity | Human KIR2DL1 |
| Verified Activity | Flow cytometric analysis of human KIR2DL1(CD158a) expression on human whole blood lymphocytes. Human whole blood lymphocytes were stained with APC-conjugated anti-Human KIR2DL1(CD158a). The histogram were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. |
| Application | |
| Recommended Dose | 10 μl/Test, 0.1 mg/ml |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Human KIR2DL1 / CD158a (rh KIR2DL1 / CD158a; TMPY-02629; NP_055033.2; Met1-His245) and conjugated with APC under optimum conditions, the unreacted APC was removed. |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | PBS solution containing 0.5% BSA and 0.03%ProClin300 |
| Research Background | Killer cell immunoglobulin-like receptor 2DL1 or KIR2DL1 is an inhibitory Natural Killer cell immunoglobulin-like receptor with two extracellular immunoglobulin domains. KIR2DL1 is a member of the Killer cell immunoglobulin-like receptor family whose members are classified by the number of the extracellular immunoglobulin domains and the length of the cytoplasm domain. KIR2DL1 is a transmembrane glycoprotein expressed by natural killer cells and subsets of T cells. KIR2DL1 down-regulates the cytotoxicity of NK cells upon recognition of specific class I major histocompatibility complex (MHC) molecules on target cells. It has been reported that the KIR2DL1 is bound to its class I MHC ligand, HLA-Cw4. The KIR2DL1-HLA-Cw4 interface exhibits charge and shape complementarity. Specificity is mediated by a pocket in KIR2DL1 that hosts the Lys80 residue of HLA-Cw4. Many residues conserved in HLA-C and KIR2DL receptors make different interactions in KIR2DL1-HLA-Cw4 and a previously reported KIR2DL2-HLA-Cw3 complex. A dimeric aggregate of KIR-HLA-C complexes was observed in one KIR2DL1-HLA-Cw4 crystal. |
| Conjucates | APC |
| Others Formats | Unconjugated/PerCP/FITC/PE |
| Antibody Types Available | 5 |
| Immunogen | Recombinant Protein: Human KIR2DL1 / CD158a protein (TMPY-02629) |
| Antigen Species | Human |
| Biology Area | ITIM/ITAM Immunoreceptors and Related Molecules |
| Stability & Storage | Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.